442 related articles for article (PubMed ID: 15771973)
1. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Schöfer H
Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
5. Effect of imiquimod in anogenital warts from HIV-positive men.
Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
[TBL] [Abstract][Full Text] [Related]
6. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
Arany I; Tyring SK; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
Antiviral Res; 1999 Aug; 43(1):55-63. PubMed ID: 10480263
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
10. Cytokine induction and modifying the immune response to human papilloma virus with imiquimod.
Slade HB
Eur J Dermatol; 1998; 8(7 Suppl):13-6; discussion 20-2. PubMed ID: 10387958
[TBL] [Abstract][Full Text] [Related]
11. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Werner RN; Westfechtel L; Dressler C; Nast A
Sex Transm Infect; 2017 Dec; 93(8):543-550. PubMed ID: 28637906
[TBL] [Abstract][Full Text] [Related]
12. Imiquimod applied topically: A novel immune response modifier.
Tyring S
Skin Therapy Lett; 2001 Mar; 6(6):1-4. PubMed ID: 11298484
[TBL] [Abstract][Full Text] [Related]
13. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
14. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Carrasco D; vander Straten M; Tyring SK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
[TBL] [Abstract][Full Text] [Related]
15. Imiqimod in clinical practice.
Trofatter KF
Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
[TBL] [Abstract][Full Text] [Related]
16. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
Cox JT
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anogenital warts with topical cidofovir].
Fernández-Morano T; Del Boz J; Frieyro-Elichegui M; Repiso JB; Padilla-España L; de Troya-Martín M
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):222-6. PubMed ID: 23182242
[TBL] [Abstract][Full Text] [Related]
18. Imiquimod: a review.
Gupta AK; Browne M; Bluhm R
J Cutan Med Surg; 2002; 6(6):554-60. PubMed ID: 12362256
[TBL] [Abstract][Full Text] [Related]
19. [Imiquimod--clinical efficacy].
Beutner KR
Ann Dermatol Venereol; 2000; 127(10 Suppl):3S19-3S21. PubMed ID: 11116859
[No Abstract] [Full Text] [Related]
20. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
Arican O; Guneri F; Bilgic K; Karaoglu A
J Dermatol; 2004 Aug; 31(8):627-31. PubMed ID: 15492435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]